Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
XNCR
#2122
Xencor, Inc.
12.7
7
-7.86%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-7.86%
Monthly Change
-3.40%
6 month change
+57.46%
Year Change
-14.64%
Previous Close
13.8
6
Open
12.7
7
Bid
Ask
Low
12.7
7
High
12.7
7
Volume
218
Markets
US Stock Market
Healthcare
XNCR
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates
Xencor Inc earnings beat by $0.51, revenue fell short of estimates
Truist Securities reiterates Buy rating on Xencor stock amid TL1A momentum
Xencor outlines 2026 pipeline plans for cancer and autoimmune drugs
Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942 (NASDAQ:XNCR)
Xencor SVP Desjarlais sells $1.15 million in shares
Xencor extends Ultomiris royalty term to 2028 with new patent
Truist Securities initiates coverage on Xencor stock with Buy rating
Xencor Inc earnings beat by $0.61, revenue fell short of estimates
Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates
Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates
Xencor stock price target raised to $18 from $15 at RBC Capital